Dyslipidemia is an important risk factor, along with smoking, hypertension, diabetes, and obesity, for cardiovascular and cerebrovascular diseases and the burden it causes has recently increased. At present, guidelines and treatment standards for dyslipidemia, and the HIRA guideline for insurance payment standard have differences, and are not also reflective of the disease aspects of Koreans. Thus, this study suggests the directions for the development of Korean dyslipidemia guideline.